作者:John Regan、Joseph Bruno、Daniel McGarry、Gregory Poli、Barbara Hanney、Shelly Bower、Jeffrey Travis、Dennis Sweeney、Bruce Miller、John Souness、Stevan Djuric                                    
                                    
                                        DOI:10.1016/s0960-894x(98)00497-1
                                    
                                    
                                        日期:1998.10
                                    
                                    A new family of PDE4 inhibitors based on a benzimidazole framework is described. Several of these compounds are orally bioavailable and show efficacy in in vivo models of inflammatory disease. (C) 1998 Elsevier Science Ltd. All rights reserved.